Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Osiris Therapeutics, Inc.    OSIR

Delayed Quote. Delayed  - 06/24 09:59:47 pm
5.18 USD   -5.82%
06/06 INVESTIGATION F : OSIR) over Potential Wrongdoing by Certain Directo..
06/02 Khang & Khang LLP Announces an Investigation of Claims against Os..
06/01 Levi & Korsinsky, LLP Announces the Commencement of an Investigat..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/20/2016 06/21/2016 06/22/2016 06/23/2016 06/24/2016 Date
5.15(c) 5.17(c) 5.2(c) 5.5(c) 5.24(c) Last
133 230 67 577 62 294 98 092 344 139 Volume
+5.32% +0.39% +0.58% +5.77% -4.73% Change
More quotes
Financials ($)
Sales 2015 94,9 M
EBIT 2015 4,40 M
Net income 2015 2,77 M
Debt 2015 -
Yield 2015 -
Sales 2016 110 M
EBIT 2016 5,03 M
Net income 2016 4,54 M
Debt 2016 -
Yield 2016 -
P/E ratio 2015 64,75
P/E ratio 2016 41,44
Capi. / Sales2015 1,88x
Capi. / Sales2016 1,62x
Capitalization 178 M
More Financials
Company
Osiris Therapeutics, Inc. engages in stem cell research and development of pharmaceutical products.Its regenerative medicine targets dermal burns, pressure ulcers, venous leg, diabetic foot ulcers, and tissue and bone repair.The company was founded by Peter A. Friedli and James S. Burns on December... 
More about the company
Surperformance© ratings of Osiris Therapeutics, Inc.
Trading Rating : - Investor Rating :
More Ratings
Latest news on OSIRIS THERAPEUTICS, INC.
06/14 OSIRIS THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
06/10 OSIRIS THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
06/06 INVESTIGATION FOR INVESTORS IN SHARE : OSIR) over Potential Wrongdoing by Certai..
06/02 Khang & Khang LLP Announces an Investigation of Claims against Osiris Therape..
06/01 Levi & Korsinsky, LLP Announces the Commencement of an Investigation Into Pos..
06/01 Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Osiris Therapeu..
05/31 Investigation of Osiris Therapeutics, Inc. Announced by Law Offices of Howard..
05/27 OSIRIS THERAPEUTICS, INC. : Other Events (form 8-K)
05/16 OSIRIS THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continue..
05/16 OSIRIS THERAPEUTICS : Provides Update Regarding NASDAQ Listing Matters
More news
Sector news : Bio Therapeutic Drugs
06/25 NOVARTIS : SC requests solicitor general to consider on biosimilars
06/24DJMedpace Files for IPO
06/24DJMEDIVATION : Glass Lewis Backs Medivation Board in Sanofi Dispute
06/24 MEDIVATION : Glass Lewis Recommends Medivation's Stockholders Support the Compan..
06/24 MEDIVATION : Glass Lewis Recommends Medivation’s Stockholders Support the ..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
06/10 Osiris chief resigns for medical reasons
06/03 Mesoblast trading halt to stay in place until June 10, bad news expected
06/03 Is It Time To Invest In Stem Cell Biotechs?
05/31 Midday Gainers / Losers
05/31 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
Advertisement
Chart OSIRIS THERAPEUTICS, INC.
Duration : Period :
Osiris Therapeutics, Inc. Technical Analysis Chart | OSIR | US68827R1086 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions